Helix BioMedix Company Executives
| HXBM Stock | USD 2.00 0.00 0.00% |
Helix BioMedix employs about 8 people. The company is managed by 2 executives with a total tenure of roughly 14 years, averaging almost 7.0 years of service per executive, having 4.0 employees per reported executive. Analysis of Helix BioMedix's management performance can provide insight into the firm performance.
| Robin Carmichael President President, COO and Director |
Helix |
Helix BioMedix Management Team Effectiveness
The company has return on total asset (ROA) of (0.59) % which means that it has lost $0.59 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2253) %, meaning that it created substantial loss on money invested by shareholders. Helix BioMedix's management efficiency ratios could be used to measure how well Helix BioMedix manages its routine affairs as well as how well it operates its assets and liabilities.Helix BioMedix Workforce Comparison
Helix BioMedix is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 314. Helix BioMedix holds roughly 8.0 in number of employees claiming about 2.55% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.17) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.17. Helix BioMedix Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Helix BioMedix Price Series Summation is a cross summation of Helix BioMedix price series and its benchmark/peer.
Helix BioMedix Notable Stakeholders
A Helix BioMedix stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Helix BioMedix often face trade-offs trying to please all of them. Helix BioMedix's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Helix BioMedix's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Robin Carmichael | President, COO and Director | Profile | |
| Kelly Forsythe | Associate Marketing | Profile |
About Helix BioMedix Management Performance
The success or failure of an entity such as Helix BioMedix often depends on how effective the management is. Helix BioMedix management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Helix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Helix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington. Helix Biomedix operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8 people.
Helix BioMedix Workforce Analysis
Traditionally, organizations such as Helix BioMedix use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Helix BioMedix within its industry.Helix BioMedix Manpower Efficiency
Return on Helix BioMedix Manpower
| Revenue Per Employee | 226.9K | |
| Revenue Per Executive | 907.5K | |
| Net Loss Per Employee | 322.5K | |
| Net Loss Per Executive | 1.3M | |
| Working Capital Per Employee | 86.2K | |
| Working Capital Per Executive | 345K |
Other Information on Investing in Helix Pink Sheet
Helix BioMedix financial ratios help investors to determine whether Helix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Helix with respect to the benefits of owning Helix BioMedix security.